Annex tables to the European Drug Report 2023
The data tables here are part of the annex of the European Drug Report 2023. National data presented here are mainly a subset of data available in the Statistical Bulletin 2023. In addition, for some indicators, these data tables also provide values for the EU as well as for EU, Türkiye and Norway (EU+2).
List of tables
- Opioids
- Table 1a. High-risk opioid use estimates for population aged 15–64 years
- Table 1b. Entrants into treatment during the year: opioids clients as a proportion of treatment demands
- Table 1c. Entrants into treatment during the year: proportion of opioids clients with injection as main route of administration
- Table 1d. Number of clients in opioid agonist treatment
- Cocaine
- Table 2a. Cocaine prevalence estimates among the general population and school students
- Table 2b. Entrants into treatment during the year - cocaine clients as a proportion of treatment demands
- Table 2c. Entrants into treatment during the year: proportion of cocaine clients with injection as main route of administration
- Amphetamines
- Table 3a. Amphetamines prevalence estimates among the general population and school students
- Table 3b. Entrants into treatment during the year - amphetamines clients as a proportion of treatment demands
- Table 3c. Entrants into treatment during the year: proportion of amphetamines clients with injection as main route of administration
- MDMA
- Cannabis
- Other indicators
- Seizures
| Country | Year of estimate | Cases per 1 000 |
|---|---|---|
| Belgium | ‒ | ‒ |
| Bulgaria | ‒ | ‒ |
| Czechia | 2021 | 1.5-1.6 |
| Denmark | 2016 | 4.0-9.6 |
| Germany | 2020 | 1.7-2.0 |
| Estonia | ‒ | ‒ |
| Ireland | 2019 | 6.6-7.3 |
| Greece | 2021 | 1.1-2.4 |
| Spain | 2020 | 1.2-2.7 |
| France | 2020 | 5.5-5.8 |
| Croatia | 2015 | 2.5-4.0 |
| Italy | 2021 | 6.2-8.7 |
| Cyprus | 2021 | 1.4-3.4 |
| Latvia | 2017 | 4.6-7.0 |
| Lithuania | 2016 | 2.7-6.5 |
| Luxembourg | 2019 | 3.3 |
| Hungary | 2010-11 | 0.4-0.5 |
| Malta | 2020 | 2.4-3.0 |
| Netherlands | 2012 | 1.1-1.5 |
| Austria | 2021 | 6.3-6.8 |
| Poland | 2014 | 0.4-0.7 |
| Portugal | 2018 | 3.0-7.0 |
| Romania | 2020 | 1.0-1.7 |
| Slovenia | 2021 | 2.8-3.3 |
| Slovakia | 2020 | 0.9–1.7 |
| Finland | 2017 | 6.9-8.6 |
| Sweden | ‒ | ‒ |
| Türkiye | 2011 | 0.2-0.5 |
| Norway | 2013 | 2.0-4.2 |
Notes
Cases per 1 000 population aged 15-64 (lower and upper limits - when not available central estimate is provided)
| Country | All opioids entrants - % | All opioids entrants - count | First-time opioids entrants - % | First-time opioids entrants - count | Previously treated opioids entrants - % | Previously treated opioids entrants - count |
|---|---|---|---|---|---|---|
| Belgium | 18.6 | 2087 | 6.6 | 252 | 25.2 | 1751 |
| Bulgaria | 62 | 694 | 22.7 | 82 | 80.9 | 587 |
| Czechia | 37.7 | 2747 | 18.7 | 470 | 36.8 | 1229 |
| Denmark | 12.5 | 639 | 8.7 | 192 | 15.6 | 430 |
| Germany | 13.8 | 6143 | 6.9 | 1696 | 23.3 | 4012 |
| Estonia | 64.9 | 315 | 49 | 74 | 71.9 | 225 |
| Ireland | 33.7 | 3509 | 12.6 | 530 | 49 | 2811 |
| Greece | 50 | 1720 | 29.4 | 432 | 65.2 | 1264 |
| Spain | 22.1 | 8502 | 11.2 | 2249 | 34.7 | 5953 |
| France | 25.6 | 9562 | 13.2 | 1229 | 37.4 | 5863 |
| Croatia | - | - | 24.4 | 130 | 87.9 | 4475 |
| Italy | 37.1 | 12593 | 22.4 | 3181 | 47.6 | 9412 |
| Cyprus | 12.4 | 91 | 7.2 | 30 | 19.4 | 57 |
| Latvia | 33.4 | 209 | 17.7 | 63 | 54.1 | 146 |
| Lithuania | 78.3 | 364 | 32.1 | 25 | 89.7 | 331 |
| Luxembourg | 40.5 | 77 | 29.8 | 17 | 45.1 | 60 |
| Hungary | 2 | 87 | 0.8 | 23 | 5.6 | 43 |
| Malta | 49.7 | 990 | 17.3 | 71 | 58.2 | 919 |
| Netherlands | 11.5 | 1262 | 6.2 | 402 | 19.3 | 860 |
| Austria | 45.8 | 1946 | 28.4 | 486 | 57.5 | 1460 |
| Poland | 13.2 | 627 | 5.9 | 138 | 21.3 | 479 |
| Portugal | 36.8 | 1152 | 19 | 321 | 57.8 | 831 |
| Romania | 20.9 | 647 | 8.5 | 173 | 44.2 | 474 |
| Slovenia | 91.4 | 192 | 84.9 | 62 | 95.1 | 97 |
| Slovakia | 11.8 | 285 | 6.9 | 72 | 16.2 | 209 |
| Finland | 39.1 | 167 | 40.2 | 66 | 38.4 | 101 |
| Sweden (1) | 26.9 | 8654 | 16.5 | 2061 | 34.8 | 6335 |
| Türkiye | 47.2 | 4413 | 30 | 1277 | 61.5 | 3136 |
| Norway (2) | 18.1 | 1058 | 11.4 | 280 | 23.1 | 778 |
| European Union | 24.8 | 65261 | 12.5 | 14527 | 38.3 | 50414 |
| EU, Türkiye and Norway | 25.4 | 70732 | 13.1 | 16084 | 38.7 | 54328 |
Notes
Data on entrants into treatment are for 2021 or most recent year available: Czechia, Spain, France, 2020; Netherlands, 2015.
(1) Sweden: data for clients entering treatment refer to hospital-based care, specialised outpatient care facilities and prison and compulsory care. Data shown are not fully representative of the national picture.
(2) Norway: the percentage of clients in treatment for opioid-related problems is a minimum value, not accounting for opioid clients registered as polydrug users.
| Country | All opioids entrants - % | All opioids entrants - count | First-time opioids entrants - % | First-time opioids entrants - count | Previously treated opioids entrants - % | Previously treated opioids entrants - count |
|---|---|---|---|---|---|---|
| Belgium | 2.9 | 81 | 0.5 | 5 | 4.1 | 71 |
| Bulgaria | 1.3 | 1 | 2.3 | 1 | 0 | 0 |
| Czechia | 5 | 3 | 3.7 | 1 | 6.5 | 2 |
| Denmark | 1.1 | 11 | 0.2 | 1 | 2 | 10 |
| Germany | 1.4 | 35 | 0.9 | 12 | 2.1 | 20 |
| Estonia | 30 | 3 | 40 | 2 | 20 | 1 |
| Ireland | 0.5 | 17 | 0 | 0 | 1.1 | 15 |
| Greece | 9.2 | 56 | 3.5 | 12 | 16.5 | 43 |
| Spain | 0.7 | 121 | 0.3 | 26 | 1.2 | 91 |
| France | 6.9 | 276 | 2.8 | 26 | 10.1 | 196 |
| Croatia | - | - | 0 | 0 | 7.3 | 8 |
| Italy | 1.8 | 216 | 0.9 | 52 | 2.7 | 164 |
| Cyprus | 2.8 | 6 | 2 | 2 | 3.5 | 4 |
| Latvia | 5.6 | 1 | 8.3 | 1 | 0 | 0 |
| Lithuania | 0 | 0 | - | - | - | - |
| Luxembourg | 34.4 | 21 | 18.8 | 3 | 40 | 18 |
| Hungary | 1 | 2 | 1.3 | 2 | 0 | 0 |
| Malta | 5.9 | 40 | 1 | 2 | 8.1 | 38 |
| Netherlands | 0.4 | 5 | 0.1 | 1 | 0.6 | 4 |
| Austria | 4.1 | 22 | 1.5 | 4 | 6.6 | 18 |
| Poland | 2 | 2 | 0 | 0 | 3.8 | 2 |
| Portugal | 0.9 | 6 | 0.2 | 1 | 2.2 | 5 |
| Romania | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovenia | 30 | 3 | 50 | 2 | 25 | 1 |
| Slovakia | 9.1 | 2 | 8.3 | 1 | 12.5 | 1 |
| Finland | 0 | 0 | 0 | 0 | 0 | 0 |
| Sweden (1) | 11.1 | 1 | - | - | - | - |
| Türkiye | 0.4 | 1 | - | - | 0.7 | 1 |
| Norway | - | - | - | - | - | - |
| European Union | 2 | 931 | 0.7 | 157 | 3.1 | 712 |
| EU, Türkiye and Norway | 2 | 932 | 0.7 | 157 | 3.1 | 713 |
Notes
Data on entrants into treatment are for 2021 or most recent year available: Czechia, Spain, France, 2020; Netherlands, 2015.
Missing cases of 30% or more for main route of administration: Czechia, Germany, the Netherlands and Slovenia.
(1) Sweden: data for clients entering treatment refer to hospital-based care, specialised outpatient care facilities and prison and compulsory care. Data shown are not fully representative of the national picture.
| Country | Count |
|---|---|
| Belgium | 15426 |
| Bulgaria | 2975 |
| Czechia (1) | 6000 |
| Denmark | 5533 |
| Germany | 81300 |
| Estonia | 1051 |
| Ireland | 11486 |
| Greece | 9039 |
| Spain | 55058 |
| France | 177100 |
| Croatia | 4480 |
| Italy | 75711 |
| Cyprus | 200 |
| Latvia | 685 |
| Lithuania | 1098 |
| Luxembourg | 1231 |
| Hungary | 577 |
| Malta | 796 |
| Netherlands (2) | 5241 |
| Austria | 20138 |
| Poland | 3523 |
| Portugal | 18185 |
| Romania | 1769 |
| Slovenia | 3078 |
| Slovakia | 590 |
| Finland | 4729 |
| Sweden | 4331 |
| Türkiye | 4413 |
| Norway | 8198 |
| European Union | 511330 |
| EU, Türkiye and Norway | 523941 |
Notes
Data on clients in opioid agonist treatment are for 2021 or most recent year available: Spain, 2020; Finland, 2019; France, Italy, 2018; Netherlands, 2015.
(1) Czechia: number of clients is an estimate derived from the treatment demand register and opioid agonist treatment provided by general practitioners.
(2) Netherlands: data on the number of clients in agonist treatment are not complete.
| Country | Year of survey | General population surveys - lifetime, all adults (15–64) | General population surveys - last 12 months, young adults (15–34) | School surveys - lifetime, students (15–16) |
|---|---|---|---|---|
| Belgium | 2018 | ‒ | 2.9 | 1 |
| Bulgaria | 2020 | 2 | 1.3 | 3 |
| Czechia | 2021 | 1.4 | 0.7 | 2 |
| Denmark | 2021 | 8.1 | 2.9 | 2 |
| Germany | 2021 | 5.6 | 3.1 | 1 |
| Estonia | 2018 | 5 | 2.8 | 2 |
| Ireland | 2019 | 8.3 | 4.8 | 3 |
| Greece | 2015 | 1.3 | 0.6 | 1 |
| Spain | 2022 | 12 | 3.1 | 2 |
| France | 2017 | 5.6 | 3.2 | 3 |
| Croatia | 2019 | 4.8 | 3.9 | 2 |
| Italy | 2017 | 6.9 | 1.7 | 2 |
| Cyprus | 2019 | 1.8 | 0.9 | 4 |
| Latvia | 2020 | 2.7 | 2.2 | 2 |
| Lithuania | 2021 | 1.8 | 0.8 | 2 |
| Luxembourg | 2019 | 2.9 | 0.9 | 2 |
| Hungary | 2019 | 1.7 | 0.6 | 3 |
| Malta | 2013 | 0.5 | – | 2 |
| Netherlands | 2021 | 7.9 | 4.7 | 2 |
| Austria | 2022 | 6.2 | 2.2 | 2 |
| Poland | 2018 | 0.7 | 0.5 | 2 |
| Portugal | 2016 | 1.2 | 0.3 | 2 |
| Romania | 2019 | 1.6 | 0.7 | 2 |
| Slovenia | 2018 | 2.7 | 1.8 | 3 |
| Slovakia | 2019 | 0.9 | 0.2 | 1 |
| Finland | 2018 | 3.2 | 1.5 | 1 |
| Sweden | 2021 | ‒ | 2.8 | 1 |
| Türkiye | 2017 | 0.2 | 0.1 | ‒ |
| Norway | 2021 | 5.8 | 2.7 | 2 |
| European Union | ‒ | 5.4 | 2.3 | ‒ |
| EU, Türkiye and Norway | ‒ | ‒ | ‒ | ‒ |
Notes
Prevalence estimates for the general population: age ranges are 18–64 and 18–34 for France, Germany, Greece and Hungary; 16–64 and 16–34 for Denmark, Estonia and Norway; 18–65 for Malta ; 17–34 for Sweden.Prevalence estimates for the school population are extracted from the 2019 ESPAD survey, except for Belgium (2019; Flanders only) and Luxembourg (2014). Germany ESPAD data refer to Bavaria only.
| Country | All cocaine entrants - % | All cocaine entrants - count | First-time cocaine entrants - % | First-time cocaine entrants - count | Previously treated cocaine entrants - % | Previously treated cocaine entrants - count |
|---|---|---|---|---|---|---|
| Belgium | 29.6 | 3325 | 28.6 | 1093 | 29.7 | 2065 |
| Bulgaria | 7.6 | 85 | 13.3 | 48 | 4.8 | 35 |
| Czechia | 0.9 | 62 | 1.1 | 28 | 1 | 32 |
| Denmark | 19.7 | 1009 | 20.8 | 457 | 19.2 | 529 |
| Germany | 8.5 | 3756 | 8.2 | 2035 | 8.7 | 1494 |
| Estonia | 2.1 | 10 | 3.3 | 5 | 1.6 | 5 |
| Ireland | 30.2 | 3139 | 38.4 | 1612 | 23.9 | 1372 |
| Greece | 17.7 | 609 | 23.6 | 346 | 13.5 | 262 |
| Spain | 45.4 | 17490 | 45.4 | 9092 | 45.1 | 7744 |
| France | 11.8 | 4424 | 10.9 | 1014 | 13.5 | 2114 |
| Croatia | - | - | 7.7 | 41 | 2.2 | 114 |
| Italy | 38.8 | 13184 | 44.5 | 6313 | 34.7 | 6871 |
| Cyprus | 29.5 | 217 | 23.4 | 98 | 38.4 | 113 |
| Latvia | 3.4 | 21 | 3.4 | 12 | 3.3 | 9 |
| Lithuania | 1.7 | 8 | 5.1 | 4 | 1.1 | 4 |
| Luxembourg | 33.2 | 63 | 28.1 | 16 | 35.3 | 47 |
| Hungary | 5.1 | 220 | 5.4 | 161 | 4 | 31 |
| Malta | 34 | 676 | 50.4 | 207 | 29.7 | 469 |
| Netherlands | 24.3 | 2675 | 20.8 | 1357 | 29.6 | 1318 |
| Austria | 14.1 | 600 | 17.6 | 301 | 11.8 | 299 |
| Poland | 2.2 | 103 | 2 | 47 | 2.4 | 54 |
| Portugal | 21.8 | 682 | 26 | 440 | 16.8 | 242 |
| Romania | 2.7 | 84 | 3.4 | 69 | 1.4 | 15 |
| Slovenia | 4.8 | 10 | 5.5 | 4 | 3.9 | 4 |
| Slovakia | 1 | 23 | 1.3 | 13 | 0.6 | 8 |
| Finland | 0.7 | 3 | 1.2 | 2 | 0.4 | 1 |
| Sweden (1) | 2 | 639 | 3.1 | 389 | 0.8 | 154 |
| Türkiye | 2.7 | 256 | 2.8 | 117 | 2.7 | 139 |
| Norway | 3.2 | 188 | 4.3 | 105 | 2.5 | 83 |
| European Union | 20.2 | 53117 | 21.7 | 25204 | 19.3 | 25405 |
| EU, Türkiye and Norway | 19.2 | 53561 | 20.7 | 25426 | 18.3 | 25627 |
Notes
Data on entrants into treatment are for 2021 or most recent year available: Czechia, Spain, France, 2020; Netherlands, 2015.
(1) Sweden: data for clients entering treatment refer to hospital-based care, specialised outpatient care facilities and prison and compulsory care. Data shown are not fully representative of the national picture.
| Country | All cocaine entrants - % | All cocaine entrants - count | First-time cocaine entrants - % | First-time cocaine entrants - count | Previously treated cocaine entrants - % | Previously treated cocaine entrants - count |
|---|---|---|---|---|---|---|
| Belgium | 2.9 | 81 | 0.5 | 5 | 4.1 | 71 |
| Bulgaria | 1.3 | 1 | 2.3 | 1 | 0 | 0 |
| Czechia | 5 | 3 | 3.7 | 1 | 6.5 | 2 |
| Denmark | 1.1 | 11 | 0.2 | 1 | 2 | 10 |
| Germany | 1.4 | 35 | 0.9 | 12 | 2.1 | 20 |
| Estonia | 30 | 3 | 40 | 2 | 20 | 1 |
| Ireland | 0.5 | 17 | 0 | 0 | 1.1 | 15 |
| Greece | 9.2 | 56 | 3.5 | 12 | 16.5 | 43 |
| Spain | 0.7 | 121 | 0.3 | 26 | 1.2 | 91 |
| France | 6.9 | 276 | 2.8 | 26 | 10.1 | 196 |
| Croatia | - | - | 0 | 0 | 7.3 | 8 |
| Italy | 1.8 | 216 | 0.9 | 52 | 2.7 | 164 |
| Cyprus | 2.8 | 6 | 2 | 2 | 3.5 | 4 |
| Latvia | 5.6 | 1 | 8.3 | 1 | 0 | 0 |
| Lithuania | 0 | 0 | - | - | - | - |
| Luxembourg | 34.4 | 21 | 18.8 | 3 | 40 | 18 |
| Hungary | 1 | 2 | 1.3 | 2 | 0 | 0 |
| Malta | 5.9 | 40 | 1 | 2 | 8.1 | 38 |
| Netherlands | 0.4 | 5 | 0.1 | 1 | 0.6 | 4 |
| Austria | 4.1 | 22 | 1.5 | 4 | 6.6 | 18 |
| Poland | 2 | 2 | 0 | 0 | 3.8 | 2 |
| Portugal | 0.9 | 6 | 0.2 | 1 | 2.2 | 5 |
| Romania | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovenia | 30 | 3 | 50 | 2 | 25 | 1 |
| Slovakia | 9.1 | 2 | 8.3 | 1 | 12.5 | 1 |
| Finland | 0 | 0 | 0 | 0 | 0 | 0 |
| Sweden (1) | 11.1 | 1 | - | - | - | - |
| Türkiye | 0.4 | 1 | - | - | 0.7 | 1 |
| Norway | - | - | - | - | - | - |
| European Union | 2 | 931 | 0.7 | 157 | 3.1 | 712 |
| EU, Türkiye and Norway | 2 | 932 | 0.7 | 157 | 3.1 | 713 |
Notes
Data on entrants into treatment are for 2021 or most recent year available: Czechia, Spain, France, 2020; Netherlands, 2015.
Missing cases of 30 % or more for main route of administation: Germany, the Netherlands and Latvia.
(1) Sweden: data for clients entering treatment refer to hospital-based care, specialised outpatient care facilities and prison and compulsory care. Data shown are not fully representative of the national picture.
| Country | Year of survey | General population surveys - lifetime, all adults (15–64) | General population surveys - last 12 months, young adults (15–34) | School surveys - lifetime, students (15–16) |
|---|---|---|---|---|
| Belgium | 2018 | ‒ | 0.8 | 1 |
| Bulgaria | 2020 | 2.1 | 1.4 | 3 |
| Czechia | 2021 | 1.8 | 0.3 | 1 |
| Denmark | 2021 | 7.9 | 1.4 | 1 |
| Germany | 2021 | 6.1 | 2.9 | 2 |
| Estonia | 2018 | 6.1 | 2.1 | 3 |
| Ireland | 2019 | 4.8 | 2.3 | 2 |
| Greece | ‒ | ‒ | ‒ | 1 |
| Spain | 2022 | 4.6 | 1.1 | 1 |
| France | 2017 | 2.2 | 0.6 | 1 |
| Croatia | 2019 | 4.6 | 3.5 | 2 |
| Italy | 2017 | 2.4 | 0.3 | 1 |
| Cyprus | 2019 | 0.4 | 0.2 | 2 |
| Latvia | 2020 | 1.8 | 1.2 | 2 |
| Lithuania | 2021 | 1.4 | 0.6 | 1 |
| Luxembourg | 2019 | 1.3 | 0.3 | 1 |
| Hungary | 2019 | 1.5 | 0.8 | 3 |
| Malta | 2013 | 0.3 | ‒ | 1 |
| Netherlands | 2021 | 6.5 | 2.7 | 1 |
| Austria | 2022 | 4.5 | 1.4 | 2 |
| Poland | 2018 | 2.4 | 1.4 | 3 |
| Portugal | 2016 | 0.4 | 0 | 2 |
| Romania | 2019 | 0.2 | 0.1 | 1 |
| Slovenia | 2018 | 2.3 | 1.1 | 1 |
| Slovakia | 2019 | 0.9 | 0.2 | 1 |
| Finland | 2018 | 4.7 | 3 | 2 |
| Sweden | 2021 | ‒ | 1.6 | 1 |
| Türkiye | 2017 | 0 | ‒ | ‒ |
| Norway | 2021 | 3.7 | 0.5 | 2 |
| European Union | ‒ | 3.6 | 1.3 | ‒ |
| EU, Türkiye and Norway | ‒ | ‒ | ‒ | ‒ |
Notes
Prevalence estimates for the general population: age ranges are 18–64 and 18–34 for France, Germany, Greece and Hungary; 16–64 and 16–34 for Denmark, Estonia and Norway; 18–65 for Malta ; 17–34 for Sweden.Prevalence estimates for the school population are extracted from the 2019 ESPAD survey, except for Belgium (2019; Flanders only) and Luxembourg (2014). Germany ESPAD data refer to Bavaria only.
| Country | All amphetamines entrants - % | All amphetamines entrants - count | First-time amphetamines entrants - % | First-time amphetamines entrants - count | Previously treated amphetamines entrants - % | Previously treated amphetamines entrants - count |
|---|---|---|---|---|---|---|
| Belgium | 9.9 | 1110 | 7 | 266 | 11.7 | 815 |
| Bulgaria | 10.6 | 119 | 19.4 | 70 | 6.6 | 48 |
| Czechia | 41.5 | 3026 | 51.6 | 1299 | 43 | 1435 |
| Denmark | 6.3 | 323 | 5.4 | 118 | 7 | 194 |
| Germany | 16.2 | 7213 | 13.6 | 3354 | 21 | 3615 |
| Estonia | 21 | 102 | 28.5 | 43 | 18.2 | 57 |
| Ireland | 0.7 | 76 | 1.1 | 47 | 0.5 | 28 |
| Greece | 1.4 | 48 | 1.8 | 27 | 1.1 | 21 |
| Spain | 1.8 | 709 | 2.1 | 418 | 1.6 | 271 |
| France | 0.5 | 201 | 0.4 | 37 | 0.5 | 86 |
| Croatia | - | - | 8.6 | 46 | 1.9 | 95 |
| Italy | 0.2 | 75 | 0.4 | 51 | 0.1 | 24 |
| Cyprus | 13 | 96 | 12 | 50 | 13.9 | 41 |
| Latvia | 21.1 | 132 | 25.6 | 91 | 15.2 | 41 |
| Lithuania | 4.7 | 22 | 11.5 | 9 | 3 | 11 |
| Luxembourg | 0.5 | 1 | 1.8 | 1 | - | - |
| Hungary | 14 | 599 | 14.2 | 422 | 11.6 | 90 |
| Malta | 0.2 | 4 | 0.5 | 2 | 0.1 | 2 |
| Netherlands | 7.4 | 817 | 7.5 | 487 | 7.4 | 330 |
| Austria | 6.8 | 289 | 7.1 | 122 | 6.6 | 167 |
| Poland | 37.9 | 1801 | 40.5 | 948 | 35 | 787 |
| Portugal | 0.3 | 9 | 0.4 | 6 | 0.2 | 3 |
| Romania | 1.5 | 48 | 1.7 | 35 | 1.2 | 13 |
| Slovenia | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovakia | 49.9 | 1206 | 54.7 | 567 | 46.2 | 594 |
| Finland | 30.9 | 132 | 25 | 41 | 34.6 | 91 |
| Sweden (1) | 8.6 | 2770 | 10.3 | 1293 | 5.5 | 997 |
| Türkiye | 27 | 2528 | 38.1 | 1620 | 17.8 | 908 |
| Norway | 14.2 | 832 | 11.2 | 275 | 16.5 | 557 |
| European Union | 8 | 20928 | 8.5 | 9850 | 7.5 | 9856 |
| EU, Türkiye and Norway | 8.7 | 24288 | 9.6 | 11745 | 8.1 | 11321 |
Notes
Data on entrants into treatment are for 2021 or most recent year available: Czechia, Spain, France, 2020; Netherlands, 2015.
Data on entrants into treatment for Sweden and Norway are for ‘stimulants other than cocaine’.
(1) Sweden: data for clients entering treatment refer to hospital-based care, specialised outpatient care facilities and prison and compulsory care. Data shown are not fully representative of the national picture.
| Country | All amphetamines entrants - % | All amphetamines entrants - count | First-time amphetamines entrants - % | First-time amphetamines entrants - count | Previously treated amphetamines entrants - % | Previously treated amphetamines entrants - count |
|---|---|---|---|---|---|---|
| Belgium | 12.6 | 119 | 6.3 | 14 | 14.6 | 101 |
| Bulgaria | 1.8 | 2 | 0 | 0 | 4.8 | 2 |
| Czechia | 65.2 | 1827 | 62.5 | 779 | 67 | 933 |
| Denmark | 1 | 3 | 0 | 0 | 1.6 | 3 |
| Germany | 1.5 | 63 | 1.1 | 23 | 2 | 38 |
| Estonia | 86.3 | 88 | 79.1 | 34 | 91.2 | 52 |
| Ireland | 21.3 | 16 | 19.1 | 9 | 25 | 7 |
| Greece | 14.6 | 7 | 18.5 | 5 | 9.5 | 2 |
| Spain | 2.7 | 19 | 3.1 | 13 | 2.2 | 6 |
| France | 19.3 | 32 | 6.7 | 2 | 23.6 | 17 |
| Croatia | - | - | 0 | 0 | 0 | 0 |
| Italy | 2.9 | 2 | 4.3 | 2 | - | - |
| Cyprus | 9.4 | 9 | 2 | 1 | 14.6 | 6 |
| Latvia | 53.8 | 63 | 47.4 | 37 | 66.7 | 26 |
| Lithuania | 17.6 | 3 | 25 | 2 | 11.1 | 1 |
| Luxembourg | - | - | - | - | - | - |
| Hungary | 2.6 | 15 | 1.7 | 7 | 6.8 | 6 |
| Malta | 0 | 0 | - | - | - | - |
| Netherlands | 1.3 | 4 | 1 | 2 | 1.9 | 2 |
| Austria | 5.8 | 15 | 1.8 | 2 | 8.9 | 13 |
| Poland | 1.8 | 32 | 1 | 9 | 3 | 23 |
| Portugal | 22.2 | 2 | 33.3 | 2 | 0 | 0 |
| Romania | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovenia | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovakia | 25.6 | 298 | 24.3 | 135 | 27.6 | 159 |
| Finland | 78.6 | 99 | 59.5 | 22 | 86.5 | 77 |
| Sweden (1) | 56.7 | 76 | - | - | - | - |
| Türkiye | 0.8 | 20 | 0.8 | 13 | 0.8 | 7 |
| Norway | - | - | - | - | - | - |
| European Union | 19.8 | 2794 | 16.3 | 1100 | 22.1 | 1474 |
| EU, Türkiye and Norway | 16.9 | 2814 | 13.3 | 1113 | 19.5 | 1481 |
Notes
Data on entrants into treatment are for 2021 or most recent year available: Czechia, Spain, France, 2020; Netherlands, 2015.
Data on entrants into treatment for Sweden and Norway are for ‘stimulants other than cocaine’.
Missing cases of 30 % or more for main route of administation: Germany, the Netherlands and Latvia.
(1) Sweden: data for clients entering treatment refer to hospital-based care, specialised outpatient care facilities and prison and compulsory care. Data shown are not fully representative of the national picture.
| Country | Year of survey | General population surveys - lifetime, all adults (15–64) | General population surveys - last 12 months, young adults (15–34) | School surveys - lifetime, students (15–16) |
|---|---|---|---|---|
| Belgium | 2018 | ‒ | 2.5 | 2 |
| Bulgaria | 2020 | 1.3 | 0.7 | 3 |
| Czechia | 2021 | 4.6 | 1.6 | 4 |
| Denmark | 2021 | 4 | 1.2 | 2 |
| Germany | 2021 | 5.6 | 2.7 | 2 |
| Estonia | 2018 | 5.4 | 2.5 | 5 |
| Ireland | 2019 | 10.3 | 6.5 | 3 |
| Greece | 2015 | 0.6 | 0.4 | 1 |
| Spain | 2022 | 5.1 | 1.8 | 1 |
| France | 2017 | 3.9 | 1.3 | 2 |
| Croatia | 2019 | 4.2 | 2.6 | 2 |
| Italy | 2017 | 2.7 | 0.8 | 1 |
| Cyprus | 2019 | 1.2 | 0.4 | 3 |
| Latvia | 2020 | 1.9 | 1.6 | 5 |
| Lithuania | 2021 | 1.8 | 0.8 | 3 |
| Luxembourg | 2019 | 2 | 0.9 | 1 |
| Hungary | 2019 | 2.5 | 1.1 | 3 |
| Malta | 2013 | 0.7 | – | 1 |
| Netherlands | 2021 | 12.2 | 7.8 | 3 |
| Austria | 2022 | 4.9 | 1.5 | 3 |
| Poland | 2018 | 1 | 0.5 | 3 |
| Portugal | 2016 | 0.7 | 0.2 | 3 |
| Romania | 2019 | 1 | 0.8 | 1 |
| Slovenia | 2018 | 2.9 | 1.3 | 3 |
| Slovakia | 2019 | 3.1 | 1 | 3 |
| Finland | 2018 | 5 | 2.6 | 1 |
| Sweden | 2021 | ‒ | 2 | 1 |
| Türkiye | 2017 | 0.4 | 0.2 | ‒ |
| Norway | 2021 | 3.9 | 1.6 | 2 |
| European Union | ‒ | 4 | 1.8 | ‒ |
| EU, Türkiye and Norway | ‒ | ‒ | ‒ | ‒ |
Notes
Prevalence estimates for the general population: age ranges are 18–64 and 18–34 for France, Germany, Greece and Hungary; 16–64 and 16–34 for Denmark, Estonia and Norway; 18–65 for Malta ; 17–34 for Sweden.Prevalence estimates for the school population are extracted from the 2019 ESPAD survey, except for Belgium (2019; Flanders only) and Luxembourg (2014). Germany ESPAD data refer to Bavaria only.
| Country | All MDMA entrants - % | All MDMA entrants - count | First-time MDMA entrants - % | First-time MDMA entrants - count | Previously treated MDMA entrants - % | Previously treated MDMA entrants - count |
|---|---|---|---|---|---|---|
| Belgium | 0.4 | 42 | 0.7 | 26 | 0.2 | 16 |
| Bulgaria | 1.3 | 15 | 3 | 11 | 0.6 | 4 |
| Czechia | 0.5 | 33 | 0.7 | 18 | 0.3 | 9 |
| Denmark | 0.3 | 15 | 0.2 | 5 | 0.4 | 10 |
| Germany | 0.5 | 213 | 0.6 | 143 | 0.3 | 60 |
| Estonia | 0.2 | 1 | 0.7 | 1 | - | - |
| Ireland | 0.1 | 12 | 0.2 | 8 | 0.1 | 4 |
| Greece | 0.2 | 8 | 0.3 | 5 | 0.2 | 3 |
| Spain | 0.2 | 72 | 0.3 | 59 | 0.1 | 12 |
| France | 0.5 | 169 | 0.7 | 62 | 0.3 | 54 |
| Croatia | - | - | 0.6 | 3 | 0.3 | 17 |
| Italy | 0.1 | 32 | 0.1 | 12 | 0.1 | 20 |
| Cyprus | 0.1 | 1 | 0.2 | 1 | - | - |
| Latvia | 1.1 | 7 | 1.4 | 5 | 0.7 | 2 |
| Lithuania | 0.4 | 2 | 2.6 | 2 | - | - |
| Luxembourg | - | - | - | - | - | - |
| Hungary | 2.8 | 121 | 2.9 | 87 | 2.7 | 21 |
| Malta | 0.3 | 5 | 0.2 | 1 | 0.3 | 4 |
| Netherlands | 0.7 | 80 | 1 | 67 | 0.3 | 13 |
| Austria | 1 | 41 | 1.3 | 23 | 0.7 | 18 |
| Poland | 0.6 | 28 | 0.9 | 21 | 0.3 | 7 |
| Portugal | 0.2 | 5 | 0.2 | 3 | 0.1 | 2 |
| Romania | 1.1 | 34 | 1.5 | 31 | 0.3 | 3 |
| Slovenia | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovakia | 0.2 | 4 | 0.2 | 2 | 0.1 | 1 |
| Finland | 0 | 0 | 0 | 0 | 0 | 0 |
| Sweden | - | - | - | - | - | - |
| Türkiye | 0.8 | 79 | 0.9 | 40 | 0.8 | 39 |
| Norway | - | - | - | - | - | - |
| European Union | 0.4 | 940 | 0.5 | 596 | 0.2 | 280 |
| EU, Türkiye and Norway | 0.4 | 1019 | 0.5 | 636 | 0.2 | 319 |
Notes
Data on entrants into treatment are for 2021 or most recent year available: Czechia, Spain, France, 2020; Netherlands, 2015.
| Country | Year of survey | General population surveys - lifetime, all adults (15–64) | General population surveys - last 12 months, young adults (15–34) | School surveys - lifetime, students (15–16) |
|---|---|---|---|---|
| Belgium | 2018 | 22.6 | 13.6 | 17 |
| Bulgaria | 2020 | 8.7 | 5.9 | 17 |
| Czechia | 2021 | 25.9 | 16.1 | 28 |
| Denmark | 2021 | 37.9 | 12 | 17 |
| Germany | 2021 | 34.7 | 17.2 | 22 |
| Estonia | 2018 | 24.5 | 16.6 | 20 |
| Ireland | 2019 | 24.4 | 13.8 | 19 |
| Greece | 2015 | 11 | 4.5 | 8 |
| Spain | 2022 | 40.9 | 19.1 | 23 |
| France | 2021 | 47.3 | 19.2 | 23 |
| Croatia | 2019 | 22.9 | 20.3 | 21 |
| Italy | 2017 | 32.7 | 20.9 | 27 |
| Cyprus | 2019 | 14.1 | 8.1 | 8 |
| Latvia | 2020 | 15 | 8.2 | 26 |
| Lithuania | 2021 | 13.7 | 8.8 | 18 |
| Luxembourg | 2019 | 23.3 | 12 | 19 |
| Hungary | 2019 | 6.1 | 3.4 | 13 |
| Malta | 2013 | 4.3 | – | 12 |
| Netherlands | 2021 | 29.8 | 19.2 | 22 |
| Austria | 2020 | 22.7 | 11.1 | 21 |
| Poland | 2018 | 12.1 | 7.8 | 21 |
| Portugal | 2016 | 11 | 8 | 13 |
| Romania | 2019 | 6.1 | 6 | 9 |
| Slovenia | 2018 | 20.7 | 12.3 | 23 |
| Slovakia | 2019 | 17 | 7.7 | 24 |
| Finland | 2018 | 25.6 | 15.5 | 11 |
| Sweden | 2021 | 17.6 | 6.5 | 5 |
| Türkiye | 2017 | 2.7 | 1.8 | ‒ |
| Norway | 2021 | 25.5 | 9.3 | 9 |
| European Union | ‒ | 29.3 | 15.1 | ‒ |
| EU, Türkiye and Norway | ‒ | ‒ | ‒ | ‒ |
Notes
Prevalence estimates for the general population: age ranges are 18–64 and 18–34 for France, Germany, Greece and Hungary; 16–64 and 16–34 for Denmark, Estonia, Sweden and Norway; 18–65 for Malta.
Prevalence estimates for the school population are extracted from the 2019 ESPAD survey, except for Belgium (2019; Flanders only) and Luxembourg (2018). Germany ESPAD data refer to Bavaria only. Due to possible overstating, Luxembourg cannabis lifetime prevalence may be slightly overestimated.
| Country | All Cannabis entrants - % | All Cannabis entrants - count | First-time Cannabis entrants - % | First-time Cannabis entrants - count | Previously treated Cannabis entrants - % | Previously treated Cannabis entrants - count |
|---|---|---|---|---|---|---|
| Belgium | 30.6 | 3429 | 45.6 | 1746 | 22.6 | 1574 |
| Bulgaria | 10.9 | 122 | 23.8 | 86 | 4.4 | 32 |
| Czechia | 14.7 | 1072 | 21.4 | 539 | 14.1 | 469 |
| Denmark | 57 | 2917 | 61.3 | 1347 | 53.5 | 1477 |
| Germany | 58.2 | 25852 | 67.9 | 16804 | 43.9 | 7564 |
| Estonia | 5.6 | 27 | 9.9 | 15 | 3.5 | 11 |
| Ireland | 21.4 | 2228 | 35.2 | 1477 | 11.7 | 671 |
| Greece | 26.1 | 899 | 40.4 | 593 | 15.5 | 301 |
| Spain | 27.5 | 10587 | 36.7 | 7334 | 16.9 | 2893 |
| France | 56.6 | 21186 | 69.7 | 6504 | 43.7 | 6851 |
| Croatia | - | - | 51.9 | 276 | 6.1 | 313 |
| Italy | 21.7 | 7376 | 29.7 | 4213 | 16 | 3163 |
| Cyprus | 44.2 | 325 | 56.2 | 235 | 27.6 | 81 |
| Latvia | 33.5 | 210 | 42.7 | 152 | 21.5 | 58 |
| Lithuania | 7.5 | 35 | 35.9 | 28 | 0.8 | 3 |
| Luxembourg | 24.7 | 47 | 38.6 | 22 | 18.8 | 25 |
| Hungary | 64.5 | 2764 | 67.4 | 2001 | 54.5 | 422 |
| Malta | 14.6 | 291 | 28 | 115 | 11.1 | 176 |
| Netherlands | 47.3 | 5202 | 55.5 | 3625 | 35.4 | 1577 |
| Austria | 29.7 | 1264 | 43.1 | 739 | 20.7 | 525 |
| Poland | 31.2 | 1482 | 36.8 | 862 | 24.7 | 556 |
| Portugal | 36.7 | 1150 | 49.4 | 836 | 21.9 | 314 |
| Romania | 58.2 | 1801 | 71.2 | 1442 | 33.5 | 359 |
| Slovenia | 3.3 | 7 | 9.6 | 7 | 0 | 0 |
| Slovakia | 19.3 | 466 | 23.6 | 244 | 14.6 | 188 |
| Finland | 14.5 | 62 | 22 | 36 | 9.9 | 26 |
| Sweden (1) | 10.1 | 3263 | 13.1 | 1633 | 6.4 | 1158 |
| Türkiye | 17.3 | 1619 | 22.1 | 942 | 13.3 | 677 |
| Norway | 27.8 | 1622 | 37.7 | 929 | 20.5 | 693 |
| European Union | 35.7 | 94064 | 45.7 | 52911 | 23.4 | 30787 |
| EU, Türkiye and Norway | 35 | 97305 | 44.7 | 54782 | 22.9 | 32157 |
Notes
Data on entrants into treatment are for 2021 or most recent year available: Czechia, Spain, France, 2020; Netherlands, 2015.
(1) Sweden: data for clients entering treatment refer to hospital-based care, specialised outpatient care facilities and prison and compulsory care. Data shown are not fully representative of the national
| Country | Drug-induced deaths - Year | Drug-induced deaths - All ages - Count | Drug-induced deaths - Cases per million population - Aged 15-64 | Drug-induced deaths - Aged 15–64 - Count | HIV diagnoses related to injecting drug use (ECDC) - Cases per million population (a) | HIV diagnoses related to injecting drug use (ECDC) - Count (a) | Injecting drug use estimate - Year of estimate | Injecting drug use estimate - Cases per 1 000 population | Syringes distributed through specialised programmes |
|---|---|---|---|---|---|---|---|---|---|
| Belgium | 2019 | 168 | 20 | 149 | 1 | 11 | 2019 | 0.5-1.0 | 1203860 |
| Bulgaria | 2021 | 20 | 4 | 18 | 2 | 14 | 2020 | 2.1-2.4 | 534 |
| Czechia | 2021 | 64 | 8 | 53 | 0.7 | 7 | 2021 | 6.0-6.2 | 9381890 |
| Denmark | 2020 | 197 | 44 | 164 | 1.7 | 10 | ‒ | ‒ | – |
| Germany | 2021 | 1826 | - | - | 1.4 | 118 | ‒ | ‒ | 4197853 |
| Estonia | 2021 | 39 | 40 | 34 | 3.8 | 5 | 2015 | 9.0-11.3 | 1634981 |
| Ireland | 2017 | 235 | 73 | 227 | 1.4 | 7 | ‒ | ‒ | 522137 |
| Greece | 2019 | 230 | 34 | 229 | 8.1 | 86 | 2021 | 0.3-0.5 | 576494 |
| Spain | 2020 | 774 | 19 | 585 | 0.9 | 44 | 2020 | 0.2-0.4 | 1551973 |
| France | 2017 | 417 | - | - | 0.7 | 44 | 2020 | 2.6-2.8 | 25145060 |
| Croatia | 2021 | 77 | 28 | 74 | 0.2 | 1 | 2015 | 1.8-2.9 | 269894 |
| Italy (1) | 2021 | 293 | 8 | 288 | 1.2 | 74 | 2021 | 2.1-3.5 | 515445 |
| Cyprus | 2021 | 10 | 17 | 10 | 5.6 | 5 | 2021 | 0.8-1.5 | 5224 |
| Latvia | 2021 | 17 | 14 | 17 | 13.2 | 25 | 2016 | 5.3-6.8 | 1116157 |
| Lithuania | 2021 | 62 | 34 | 61 | 11.1 | 31 | 2016 | 4.4-4.9 | 264647 |
| Luxembourg | 2021 | 5 | 11 | 5 | 4.7 | 3 | 2019 | 1.9 | 430281 |
| Hungary | 2021 | 42 | 6 | 41 | 0 | 0 | 2015 | 1 | 39925 |
| Malta | 2021 | 5 | - | - | 0 | 0 | ‒ | ‒ | 106276 |
| Netherlands | 2021 | 298 | 23 | 262 | 0.2 | 3 | 2015 | 0.07-0.09 | – |
| Austria | 2021 | 235 | 39 | 234 | 1.6 | 14 | ‒ | ‒ | 12708532 |
| Poland | 2020 | 229 | 7 | 187 | 0.3 | 13 | ‒ | ‒ | 88862 |
| Portugal | 2020 | 63 | 9 | 58 | ‒ | ‒ | 2015 | 1.0-4.5 | 1132770 |
| Romania | 2021 | 30 | 2 | 30 | 2.5 | 48 | ‒ | ‒ | 341791 |
| Slovenia | 2021 | 65 | 44 | 60 | 1.9 | 4 | ‒ | ‒ | 458197 |
| Slovakia | 2021 | 28 | 7 | 27 | 0.2 | 1 | ‒ | ‒ | 21125 |
| Finland | 2021 | 287 | 79 | 271 | 1.8 | 10 | 2017 | 7.4 | 6595051 |
| Sweden | 2021 | 450 | 64 | 410 | 0.3 | 3 | ‒ | ‒ | 1742203 |
| Türkiye | 2021 | 270 | 5 | 269 | 0.1 | 11 | ‒ | ‒ | 2564798 |
| Norway | 2021 | 241 | 63 | 222 | 0.7 | 4 | 2021 | 1.9-2.4 | 3800000 |
| European Union | ‒ | 6166 | 18.3 | 3494 | 1.3 | 581 | ‒ | ‒ | – |
| EU, Türkiye and Norway | ‒ | 6677 | 15.9 | 3985 | 1.1 | 596 | ‒ | ‒ | – |
Notes
Overdose data must be interpreted with caution. Methodological differences should be considered when comparing between countries. In some cases, the age band is not specified, and these cases were not included in the calculations of mortality rate referring to the population aged 15–64 years: Germany (1 826), France (417) and Malta (5).
HIV diagnoses related to injecting drug use are from 2020.
Injecting drug use estimates are cases per 1 000 population aged 15-64 (lower and upper limits - when not available central estimate is provided).
Syringes distributed through specialised programmes refer to 2021, except for Spain (2020), Germany (2018; not all sites covered), France (2018) and Italy (2017; data from about half of all sites).
| Country | Heroin - Quantity seized (kg) | Heroin - Number of seizures (count) | Cocaine - Quantity seized (kg) | Cocaine - Number of seizures (count) | Amphetamine (2) - Quantity seized (kg) | Amphetamine (2) - Number of seizures (count) | Methamphetamine (2) - Quantity seized (kg) | Methamphetamine (2) - Number of seizures (count) | MDMA, MDA, MDEA - Quantity seized (tablets) | MDMA, MDA, MDEA - Quantity seized (kg) | MDMA, MDA, MDEA - Number of seizures (count) | Cannabis resin - Quantity seized (kg) | Cannabis resin - Number of seizures (count) | Herbal cannabis - Quantity seized (kg) | Herbal cannabis - Number of seizures (count) | Cannabis oil - Quantity seized (kg) | Cannabis oil - Quantity seized (litre) | Cannabis oil - Number of seizures (count) | Cannabis plants - Quantity seized (plants) | Cannabis plants - Quantity seized (kg) | Cannabis plants - Number of seizures (count) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belgium | 1,554 | 1,810 | 96,313 | 5,228 | 29 | 2,278 | 114 | 130 | 456725 | 249 | 1,450 | 13303 | 6393 | 639 | 30370 | - | (53) | 51 | - | - | 672 |
| Bulgaria | 1,158 | 34 | 12 | 34 | 263 | 49 | 170 | 38 | 2475 | 260 | 35 | 2 | 16 | 10407 | 95 | - | - | - | 24265 | 28467 | 112 |
| Czech Republic | 107 | 88 | 181 | 128 | 1 | 45 | 33 | 2,404 | 9308 | 4 | 222 | 1 | 55 | 1369 | 5103 | 1 | - | 3 | 17237 | - | 442 |
| Denmark | - | - | 397 | 4,287 | 160 | 2,103 | 3 | 279 | 6342 | - | 212 | 3035 | 16950 | 392 | 2755 | - | 5 | 119 | 9391 | 81 | - |
| Germany (1) | 222 | - | 21,549 | - | 1,318 | - | 381 | - | - | - | - | 7411 | - | 949 | - | - | - | - | - | - | - |
| Estonia | < 1 | 17 | 16 | 152 | 26 | 387 | 3 | 68 | - | 30 | 132 | 105 | 18 | 117 | 667 | - | - | - | - | 75 | 33 |
| Ireland (1) | 88 | 1,404 | 670 | 2,674 | - | 335 | - | 52 | - | - | 389 | - | 205 | - | 7,002 | - | - | - | - | - | 659 |
| Greece | 364 | 2,658 | 1,086 | 971 | < 1 | 9 | 59 | 473 | 590 | - | 81 | 4463 | 309 | 5899 | 7505 | 2 | - | 26 | 87946 | - | 671 |
| Spain | 235 | 7,873 | 48,882 | 38,294 | 288 | 2,717 | 163 | 591 | 643553 | 430 | 2,461 | 672678 | 152467 | 130092 | 138893 | 88 | - | 196 | 3203074 | - | 4525 |
| France | 1,300 | - | 26,500 | - | 226 | - | - | - | 1454085 | - | - | 72400 | - | 39500 | - | - | - | - | 101771 | - | - |
| Croatia | 250 | 119 | 745 | 413 | 110 | 1,059 | < 1 | 26 | - | 7 | 313 | 2 | 278 | 1190 | 5636 | - | - | - | 14776 | - | 225 |
| Italy | 568 | 1,720 | 20,066 | 7,785 | 9 | 97 | 28 | 205 | 6269 | 8 | 226 | 20084 | 8290 | 47043 | 7324 | 21 | 29 | 52 | 300448 | - | 1353 |
| Cyprus | < 1 | 13 | 5 | 126 | - | - | 4 | 161 | - | - | 10 | < 1 | 11 | 241 | 662 | - | - | - | 190 | - | 28 |
| Latvia | < 1 | 3 | 3 | 126 | 13 | 219 | 17 | 358 | 189094 | 6 | 502 | 1083 | 109 | 140 | 1056 | - | < 1 | 7 | - | 231 | 60 |
| Lithuania | 2 | 93 | 5 | - | 25 | 463 | 25 | 129 | - | 7 | 75 | 187 | - | 253 | - | < 1 | - | 2 | - | - | - |
| Luxembourg | 2 | 81 | 4 | 218 | 2 | 10 | - | - | 559 | - | 9 | 39 | 486 | 14 | 528 | < 1 | - | 1 | - | - | - |
| Hungary | 13 | 41 | 26 | 325 | 54 | 936 | 2 | 192 | 20788 | 1 | 448 | 3 | 103 | 847 | 2811 | - | 8 | 31 | 4701 | - | 184 |
| Malta | 1 | 25 | 762 | 54 | < 1 | 2 | < 1 | 2 | - | < 1 | 4 | 27 | 17 | 188 | 112 | - | - | - | 56 | - | 10 |
| Netherlands (1) | 1,734 | - | 71,796 | - | 19 | - | 20 | - | - | 259 | - | 172 | - | 734 | - | - | - | - | 399376 | - | - |
| Austria | 72 | 1,096 | 81 | 1,664 | 83 | 1,068 | 10 | 535 | 89975 | 14 | 775 | 367 | 647 | 739 | 11393 | 8 | - | 60 | 41230 | - | 552 |
| Poland | 120 | 1 | 2,133 | 13 | 2084 | - | 163 | 12 | 53121 | 185 | - | 932 | 19 | 9167 | 194 | 5 | - | - | 53579 | - | 1 |
| Portugal | 23 | 270 | 9,916 | 513 | 1 | 23 | < 1 | 2 | 541 | 1 | 78 | 14821 | 1081 | 1289 | 449 | < 1 | 5 | 7 | 26526 | - | 216 |
| Romania | 1,437 | 244 | 875 | 541 | 8 | 276 | 1 | 23 | 48594 | 3 | 634 | 6 | 80 | 498 | 3531 | - | < 1 | 3 | - | - | 140 |
| Slovenia | 226 | 348 | 828 | 325 | 98 | 155 | 9 | 26 | 245350 | 123 | 29 | < 1 | 55 | 1205 | 2867 | - | - | - | 22852 | - | 148 |
| Slovakia | 36 | 59 | < 1 | 27 | < 1 | 2 | 24 | 938 | 942 | < 1 | 80 | 31 | 14 | 133 | 1071 | < 1 | - | 1 | 425 | - | 22 |
| Finland | < 1 | 23 | 63 | 328 | 393 | 1,660 | 2 | 81 | 84100 | 5 | 374 | 20 | 88 | 667 | 933 | - | - | - | 17100 | - | 1506 |
| Sweden | 11 | 689 | 394 | 3,606 | 1,555 | 7,923 | 9 | 471 | 148619 | (39) | 1,571 | 4467 | 13872 | 2200 | 7893 | 5 | 5 | 250 | - | - | - |
| Türkiye | 22202 | 14924 | 2841 | 2961 | 3519 | 2,442 | 5,528 | 57,897 | 7618013 | - | 4,581 | 33068 | 9807 | 31048 | 52510 | - | 9 | 4 | 75702155 | - | 4646 |
| Norway | 33 | 510 | 160 | 1,291 | 572 | 3,328 | 4 | 133 | 18805 | 11 | 728 | 1513 | 5907 | 737 | 2805 | - | 3 | - | - | - | - |
| European Union | 9522 | 18709 | 303308 | 67832 | 6766 | 21816 | 1242 | 7196 | 3461035 | 1632 | 10110 | 815639 | 201631 | 255922 | 240289 | 129 | 106 | 809 | 4324803 | 32441 | 11559 |
| EU, Türkiye and Norway | 31756 | 34143 | 306310 | 72084 | 10858 | 27586 | 6774 | 65226 | 11097853 | 1643 | 15419 | 850220 | 217345 | 287708 | 295604 | 129 | (18 | 813 | 80026958 | 32441 | 16205 |
Notes
(1) Data on number and quantity of seizures do not include all relevant law enforcement units and should be considered partial, minimum figures. See below:
German Customs: https://www.zoll.de/DE/Presse/Zolljahresstatistik_2021/_functions/faq_5…
Dutch Customs: https://open.overheid.nl/repository/ronl-ae341114359e6f908dcab7e401b434…
Irish Customs, only amounts of quantities siezed: https://www.revenue.ie/en/search.aspx?q=Revenue%20seize%20cocaine%202020
(2) Amphetamines and methamphetamines tablets were converted to mass-equivalents by assuming a mass of 0.25 grams per tablet.
Methamphetamine: methamphetamine/methylamphetamine